Drugs.com - Pharma Industry News

Tirzepatide, Semaglutide Not Cost-Effective at Current Prices

WEDNESDAY, March 19, 2025 -- Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online March 14 in JAMA Health Forum.Jennifer H. Hwang, D.O., from the University of Chicago, and...

Mar 19, 2025 - 18:23
 0
Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
WEDNESDAY, March 19, 2025 -- Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online March 14 in JAMA Health Forum.Jennifer H. Hwang, D.O., from the University of Chicago, and...
Read More

Tags:

Previous Article

Few Nonsurgical Treatments Show Effectiveness for Low Back Pain

Next Article

Prevalence of Pediatric-Onset Chronic Conditions, Functional Limitations Increasing

Related Posts

Monthly News Roundup - February 2025

Monthly News Roundup - February 2025

Mar 2, 2025  0

1990 to 2021 Saw Global Decline in Mortality Rate for Suicide

1990 to 2021 Saw Global Decline in Mortality Rate for S...

Mar 5, 2025  0

Screen Time Tied to Manic Symptoms in Preteens

Screen Time Tied to Manic Symptoms in Preteens

Feb 24, 2025  0